These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37535442)

  • 1. Immunomodulatory effect of vitamin D supplementation on Behçet's disease patients: effect on nitric oxide and Th17/Treg cytokines production.
    Oubouchou R; -Djeraba ZAA; Kemikem Y; Otmani F; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):1-10. PubMed ID: 37535442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D status in Algerian Behçet's disease patients: an immunomodulatory effect on NO pathway.
    Djeraba Z; Benlabidi F; Djaballah-Ider FZ; Medjeber O; Arroul-Lammali A; Belguendouz H; Otmani F; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):243-250. PubMed ID: 28532201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
    Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
    Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin D deficiency and replacement on endothelial functions in Behçet's disease.
    Can M; Gunes M; Haliloglu OA; Haklar G; Inanç N; Yavuz DG; Direskeneli H
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S57-61. PubMed ID: 23020973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
    Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The status of serum vitamin D in patients with active Behcet's disease compared with controls.
    Khabbazi A; Rashtchizadeh N; Ghorbanihaghjo A; Hajialiloo M; Ghojazadeh M; Taei R; Kolahi S
    Int J Rheum Dis; 2014 May; 17(4):430-4. PubMed ID: 24118939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Salivary Cytokines and Nitric Oxide Levels in Behçet's Disease: Interleukin-32, a Novel Player in Disease Prognosis.
    Hadjimi Z; Belguendouz H; Benchabane S; Ghozali NEH; Amri M; Kocheida R; Hakem D; Biad A; Otmani F; Kemikem Y; Terahi M; Touil-Boukoffa C
    Endocr Metab Immune Disord Drug Targets; 2023; 23(3):347-355. PubMed ID: 35549879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17A and IFN-γ are Up-regulated in CD4 and γδ T Cells in Active Behcet's Disease Patients.
    Abbasova V; Gül A; Saruhan-Direskeneli G
    Immunol Lett; 2022 Feb; 242():37-45. PubMed ID: 34838533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
    Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
    J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.
    Djaballah-Ider F; Djeraba Z; Chemli M; Dammene-Debbihe N; Lounis D; Belguendouz H; Medour Y; Chaib S; Touil-Boukoffa C
    Inflammopharmacology; 2018 Jun; 26(3):725-735. PubMed ID: 29600486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Behçet's disease and systemic lupus erythematosus.
    Mehana NA; Ghaiad HR; Hassan M; Elsabagh YA; Labib S; Abd-Elmawla MA
    Life Sci; 2022 Nov; 309():120965. PubMed ID: 36155183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.
    Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M
    Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3
    Marinho A; Carvalho C; Boleixa D; Bettencourt A; Leal B; Guimarães J; Neves E; Oliveira JC; Almeida I; Farinha F; Costa PP; Vasconcelos C; Silva BM
    Immunol Res; 2017 Feb; 65(1):197-206. PubMed ID: 27423437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.
    Chekaoui A; Belguendouz H; Lahmar K; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
    Int Immunopharmacol; 2020 Mar; 80():106119. PubMed ID: 31927504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between vitamin D levels and oxidative stress markers in Egyptian Behcet's disease patients.
    Omar HS; Taha FM; Fouad S; Ibrahim FA; El Gendy A; Bassyouni IH; El-Shazly R
    Orphanet J Rare Dis; 2022 Jul; 17(1):264. PubMed ID: 35841050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency.
    Fassio A; Gatti D; Rossini M; Bertelle D; Bixio R; Viapiana O; Milleri S; Benini C; Pistillo F; Zanetti G; Adami G
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.